abstract |
<p> METHODS FOR THE TREATMENT, PREVENTION AND / OR MANAGEMENT OF MULTIPLE MYELOMA ARE DESCRIBED. THE SPECIFIC METHODS INCLUDE THE ADMINISTRATION OF AN IMMUNOMODULATOR COMPOUND, FOR EXAMPLE, LENALIDOMIDE OR POMALIDOMIDE WITH AN ANTI-CS1 ANTIBODY, FOR EXAMPLE, ELOTUZUMAB IN PATIENTS THAT HAVE RECEIVED A TRANSPLANTATION. |